Unidad de Investigacion, Hospital Galdakao-Usansolo, CIBER Epidemiología y Salud Pública, Galdakao, Vizcaya, Spain.
Arthritis Care Res (Hoboken). 2012 Apr;64(4):563-72. doi: 10.1002/acr.21570.
We evaluated patient satisfaction with total hip replacement (THR) to establish cut points of sufficient improvement based on the patient acceptable symptom state (PASS) and receiver operating characteristic (ROC) curves, and compared them with measures derived from the minimum clinically important difference (MCID), taking into account patients' baseline status.
Two cohorts of prospectively recruited patients on waiting lists for THR were studied. Sociodemographic data and comorbidities were recorded. Patients completed the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and other patient-reported outcomes questionnaires before THR and 6 months afterward. Cut points of sufficient improvement were established by the PASS, ROC, and MCID and were compared.
Patients satisfied with THR had, by preintervention WOMAC tertiles, gains of 19.4, 34.1, and 49.3 in the WOMAC pain domain and 17.8, 30.8, and 41.4 in the WOMAC functional limitation domain. The PASS cut points determined were 20, 25, and 25 for postintervention WOMAC pain and 28, 35, and 42 for functional limitation. ROC cut points were 19, 25, and 25 for postintervention pain and 26.4, 39, and 40 for functional limitation. Agreement among cut points classifying patients as responders to THR was 1.0 for pain with both PASS and ROC, and 0.85 for functional limitation; 0.6 for pain between MCID and PASS or ROC, and 0.58 and 0.60 for functional limitation.
Cut points of expected gain after THR can help clinicians, researchers, and managers to identify suitable candidates for THR, although such measures must be used with caution.
通过患者可接受症状状态(PASS)和受试者工作特征(ROC)曲线评估全髋关节置换术(THR)的患者满意度,并确定基于 PASS 和 ROC 曲线的足够改善的截断点,同时考虑到患者的基线情况,将其与最小临床重要差异(MCID)得出的测量值进行比较。
对等待 THR 的前瞻性招募患者的两个队列进行了研究。记录了社会人口统计学数据和合并症。患者在 THR 之前和之后 6 个月完成了西部安大略省和麦克马斯特大学骨关节炎指数(WOMAC)和其他患者报告的结果问卷。通过 PASS、ROC 和 MCID 确定了足够改善的截断点,并进行了比较。
通过术前 WOMAC 三分位数,THR 满意的患者 WOMAC 疼痛域的获益分别为 19.4、34.1 和 49.3,WOMAC 功能限制域的获益分别为 17.8、30.8 和 41.4。确定的 PASS 截断点为术后 WOMAC 疼痛的 20、25 和 25,功能限制的 28、35 和 42。ROC 截断点为术后疼痛的 19、25 和 25,功能限制的 26.4、39 和 40。将患者分类为 THR 反应者的截断点之间的一致性为 PASS 和 ROC 的疼痛为 1.0,功能限制为 0.85;PASS 或 ROC 与 MCID 之间的疼痛为 0.6,功能限制为 0.58 和 0.60。
THR 后预期获益的截断点可以帮助临床医生、研究人员和管理人员识别适合 THR 的候选者,但必须谨慎使用这些措施。